PTC (NasdaqGS:PTC) is expanding its relationship with Hamilton Medical, which is adopting PTC's Codebeamer ALM to replace ...

NEEDHAM, Mass.--(BUSINESS WIRE)--PTC (NASDAQ: PTC) today announced the availability of its Medical Device Industry Value-Ready Deployment™ (VRD). This offering is a set of pre-configured, ...

Collaboration agreement formed to advance market-specific ALM-PLM solutions Codebeamer ALM solution selected to enhance collaboration, validation, traceability, and regulatory compliance across ...

All versions of PTC's Axeda agent and desktop server are affected by the Access:7 cyber vulnerabilities, according to the FDA's alert to device users and manufacturers. The FDA warned that "successful ...

NEEDHAM, Mass.--(BUSINESS WIRE)--March 1, 2005--PTC (Nasdaq: PMTC), the Product Development Company(TM), today announced the general availability of the PTC Medical Device Template, combining leading, ...

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +93.35% and +16.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Golden Lee Scott, Executive Vice President and Chief Medical Officer at PTC Therapeutics, Inc. (NASDAQ: PTCT), recently sold 897 shares of the company’s common stock. The transaction, which occurred ...

SOUTH PLAINFIELD, N.J., April 14, 2021-- PTC Therapeutics, Inc. (NASDAQ: PTCT) today introduced a new no-charge, patient-initiated testing program in the United States for individuals who have ...

Good morning, everyone. Thanks for joining Jefferies Healthcare Conference in London. My name is Clara Dong, one of the biotech analysts here. So here sitting next to me, we have the team of PTCT ...

Joseph McIntosh, M.D., has jumped ship from PTC Therapeutics and landed at gene therapy biotech Aruvant Sciences as its new chief medical officer, effective immediately. The biotech came into being ...